# OnCo record nct07492641 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07492641/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07492641", "NCT07492641" ;
  schema:name "BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease"@en ;
  schema:alternateName "KANDELA-302"@en ;
  schema:description "A phase 3 trial testing BGB-43395 in HR-positive / HER2-negative breast cancer, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07492641/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07492641> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2026-05-22" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:drugs <https://onco.cc/drugs/bgb-43395/> ;
  onco:companies <https://onco.cc/companies/beone/> .